Recent research into retatruptide peptide highlight promising possibility for treating excess body and type 2 diabetes mellitus. The peptide, a dual stimulator of GLP-1 and glucose-dependent insulinotropic polypeptide, seems to present improved weight loss and blood sugar management versus existing therapies. Further clinical trials are required to